Hematology Clinical Trials
Pediatric Hematology Clinical Trials at Monroe Carell allow children with blood disorders and their families to participate in national and international research studies. If your child is eligible for a study, you can help improve our understanding of hematologic disorders. This can determine the best treatments for your child and other patients.
Our clinical trials include studies that investigate the cause, development and effects of hematologic disorders. We also pursue studies to improve population health and to discover new treatment options for our patients.
Meet Your Care Team
Michael R. DeBaunMD, MPH
- Division of Pediatric Hematology/Oncology, Pediatric Hematology/Oncology, Sickle Cell Disease
Heather L. McDanielMD, MSCI
- General Hematology and Oncology, Hemostasis and Thrombosis, Pediatric Hematology/Oncology
Why Choose Hematology Clinical Trials at Monroe Carell
Monroe Carell offers a nationally recognized, federally funded Hemophilia Treatment Center (HTC). Our clinic is part of a network of about 140 HTCs in the United States. National studies show that children treated at HTCs spend less time in the hospital, less time away from school, and have better outcomes and lower health care costs.
- Experience in blood disorders
Our medical professionals and family support team members have experience and special interest in caring for children and young adults with blood disorders and blood clotting problems. We work closely with your family to determine the best treatment options and approach.
- Comprehensive care
We offer a comprehensive program for care of children with bleeding, clotting and blood cell disorders within our clinic as well as throughout the hospital. Our team consists of physicians, clinical nurses, case managers, social workers, child life specialists and pharmacists. All team members work to provide complete care and education for you and your child.
The Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease is a nationally recognized program that brings together primary care providers and specialists from local institutions to treat individuals with sickle cell disease under one roof.